Summary In the double-blind, cross-over trial, triazolam (0.25 mg) was analyzed from flunitrazepam (1 mg) in the typical midwinter sleeplessness that is generally noticed among usually healthier individuals in Northern Norway. Each individual drug was presented for 5 evenings, in random order, with a 5-night time placebo interval concerning the act